Mira Pharmaceuticals, Common Stock Current Valuation
| MIRA Stock | 1.32 0.06 4.76% |
Valuation analysis of MIRA Pharmaceuticals, helps investors to measure MIRA Pharmaceuticals,'s intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of November 25, 2024, Enterprise Value Over EBITDA is expected to decline to -12.71. In addition to that, Enterprise Value Multiple is expected to decline to -12.71. Fundamental drivers impacting MIRA Pharmaceuticals,'s valuation include:
Price Book 6.1169 | Enterprise Value 18.3 M | Enterprise Value Ebitda (1.45) |
Undervalued
Today
Please note that MIRA Pharmaceuticals,'s price fluctuation is risky at this time. Calculation of the real value of MIRA Pharmaceuticals, is based on 3 months time horizon. Increasing MIRA Pharmaceuticals,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since MIRA Pharmaceuticals, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MIRA Stock. However, MIRA Pharmaceuticals,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.32 | Real 5.09 | Target 16.5 | Hype 1.28 | Naive 0.91 |
The real value of MIRA Stock, also known as its intrinsic value, is the underlying worth of MIRA Pharmaceuticals, Company, which is reflected in its stock price. It is based on MIRA Pharmaceuticals,'s financial performance, growth prospects, management team, or industry conditions. The intrinsic value of MIRA Pharmaceuticals,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of MIRA Pharmaceuticals, Common helps investors to forecast how MIRA stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MIRA Pharmaceuticals, more accurately as focusing exclusively on MIRA Pharmaceuticals,'s fundamentals will not take into account other important factors: MIRA Pharmaceuticals, Common Company Current Valuation Analysis
MIRA Pharmaceuticals,'s Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current MIRA Pharmaceuticals, Current Valuation | 18.33 M |
Most of MIRA Pharmaceuticals,'s fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MIRA Pharmaceuticals, Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
MIRA Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for MIRA Pharmaceuticals, is extremely important. It helps to project a fair market value of MIRA Stock properly, considering its historical fundamentals such as Current Valuation. Since MIRA Pharmaceuticals,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MIRA Pharmaceuticals,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MIRA Pharmaceuticals,'s interrelated accounts and indicators.
Click cells to compare fundamentals
MIRA Current Valuation Historical Pattern
Today, most investors in MIRA Pharmaceuticals, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various MIRA Pharmaceuticals,'s growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of MIRA Pharmaceuticals, current valuation as a starting point in their analysis.
MIRA Pharmaceuticals, Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, MIRA Pharmaceuticals, Common has a Current Valuation of 18.33 M. This is 99.87% lower than that of the Pharmaceuticals sector and 99.61% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.89% higher than that of the company.
MIRA Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MIRA Pharmaceuticals,'s direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MIRA Pharmaceuticals, could also be used in its relative valuation, which is a method of valuing MIRA Pharmaceuticals, by comparing valuation metrics of similar companies.MIRA Pharmaceuticals, is currently under evaluation in current valuation category among its peers.
MIRA Fundamentals
| Return On Equity | -7.49 | ||||
| Return On Asset | -1.78 | ||||
| Current Valuation | 18.33 M | ||||
| Shares Outstanding | 16.56 M | ||||
| Shares Owned By Insiders | 27.20 % | ||||
| Shares Owned By Institutions | 5.95 % | ||||
| Number Of Shares Shorted | 1.26 M | ||||
| Price To Book | 6.12 X | ||||
| EBITDA | (3.46 M) | ||||
| Net Income | (11.98 K) | ||||
| Total Debt | 5.06 K | ||||
| Book Value Per Share | 0.30 X | ||||
| Cash Flow From Operations | (5.63 M) | ||||
| Short Ratio | 0.47 X | ||||
| Earnings Per Share | (0.55) X | ||||
| Target Price | 12.08 | ||||
| Market Capitalization | 21.86 M | ||||
| Total Asset | 4.93 M | ||||
| Retained Earnings | (21.29 M) | ||||
| Working Capital | (875.63 K) | ||||
| Net Asset | 4.93 M |
About MIRA Pharmaceuticals, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MIRA Pharmaceuticals, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MIRA Pharmaceuticals, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MIRA Pharmaceuticals, Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether MIRA Pharmaceuticals, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MIRA Pharmaceuticals,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mira Pharmaceuticals, Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mira Pharmaceuticals, Common Stock:Check out MIRA Pharmaceuticals, Piotroski F Score and MIRA Pharmaceuticals, Altman Z Score analysis. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MIRA Pharmaceuticals,. If investors know MIRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MIRA Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.55) | Return On Assets (1.78) | Return On Equity (7.49) |
The market value of MIRA Pharmaceuticals, is measured differently than its book value, which is the value of MIRA that is recorded on the company's balance sheet. Investors also form their own opinion of MIRA Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is MIRA Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MIRA Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect MIRA Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MIRA Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if MIRA Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MIRA Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.